Abstract:Introduction: Naloxone is an effective antidote, but its short half-life means repeated doses, and infusions are often required. We investigated the effectiveness of adding intramuscular naloxone to titrated intravenous naloxone in opioid overdose in preventing recurrence of respiratory depression. Methods: This double-blinded randomised placebo-controlled trial was conducted in patients with suspected opioid poisoning and respiratory depression (respiratory rate <10 breaths/min or oxygen saturation <93%). Patients were randomised to receive either intramuscular naloxone 1,600 µg or saline placebo. All patients received titrated intravenous naloxone 100 µg and were managed on an opioid poisoning care pathway. The primary outcome was recurrence of respiratory depression within 4 h. Secondary outcomes were the proportion receiving naloxone infusions, number of naloxone boluses administered, reversal of respiratory depression at 10 min, and precipitation of opioid withdrawal (any symptom). Results: Recurrence of respiratory depression within 4 h was less common in 28/69 (41%) patients receiving intramuscular naloxone versus 48/67 (72%) patients receiving placebo (difference 31%, 95% CI: 13-46%; P < 0.001). Fewer naloxone infusions (5/69; 7% versus 25/67; 37%, difference 30%, 95% CI: 15 to 55%; P < 0.001) and fewer naloxone doses were administered (median 2, IQR: 1 to 5, versus median 5, IQR: 2 to 8; P = 0.001) in the intramuscular group. Reversal of respiratory depression at 10 min was similar between groups (51/69; 74% intramuscular naloxone versus 47/67; 70% placebo; P = 0.703). Opioid withdrawal occurred in 35/69 (51%) given intramuscular naloxone compared to 28/67 (42%) in the placebo group (difference 9%; 95% CI: -8 to 27%; P = 0.308). Discussion: The favourable pharmacokinetics of intramuscular naloxone, particularly its longer duration of activity, likely explains the improved effectiveness with lower recurrence of respiratory depression. Conclusion: The addition of intramuscular naloxone 1,600 µg to titrated intravenous naloxone prolonged effective reversal of respiratory depression, with fewer naloxone doses and infusions given, and no significant difference in patients developing withdrawal.

The Clinical Benefits of Aminophylline Plus Naloxone on Primary Apnea in Premature Infants

Pharmacodynamics of theophylline in treatment of idiopathic apnea in premature infants

Plasma Beta-Endorphin Concentration and Naloxone Treatment in Primary Apnea of Prematurity

Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Caffeine citrate improves outcomes of apnea of prematurity based on gestational ages

[Application of Neurally Adjusted Ventilatory Assist in Preterm Infants with Respiratory Distress Syndrome].

NALOXONE DECREASES THE DURATION OF PRIMARY APNEA WITH NEONATAL ASPHYXIA

Effect of Naloxone on Plasma Beta-Endorphin and Vasoactive Intestinal Peptide in Neonatal Asphyxia

Effect of Aminophylline in Preventing Renal Dysfunction among Neonates with Prenatal Asphyxia: A Clinical Trial

Effects of aminophyllinein preventing renal failure in premature neonates with asphyxia in Isfahan-Iran

Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats.

CLINICAL EFFECTS OF USING NALOXONE FOR EMERGENCY

Outcomes of noninvasive neurally adjusted ventilatory assist and nasal continuous positive airway pressure in preterm infants: a systematic review and meta-analysis

Pharmacokinetics of Caffeine Citrate and the Progress of Its Application in the Treatment for Apnea of Prematurity

Clinical study on non-invasive positive pressure ventilation combined with naloxone in the treatment of acute exacerbation of chronic obstructive pulmonary disease complicated with type Ⅱ respiratory failure

Effects of Aminophylline on plasma nitric oxide and endothelin used at the early stage of resuscitation in rats

Effectiveness of intramuscular naloxone 1,600 μg in addition to titrated intravenous naloxone 100 μg for opioid poisoning: a randomised controlled trial

Study about Aminophylline at the Early Stage of Resuscitation in the Rats with Sudden Cardiac Arrest

Efficacy of Nalmefene Antagonizing Postoperative Respiratory Depression Induced by Opioids:A Multicenter,randomized,double-Blind,positive Drug-Controlled Study

Application of nalmefene hydrochloride in pediatric laryngeal mask anesthesia

Clinical efficacy of treatment with high-dose naloxone in comatose patients in the emergency medicine department